Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (554)	2/13/1999 3:09:00 PM
From: W PAUL	Respond to of 1073

Regarding the MZ post is Collagenex's (CGPI) Metatstat a monoclonal antibody? biz.yahoo.com A very different company and product but $3.1m revenues off the first 6 weeks of their Periostat launch coupled with management cautions about continuing losses reminds me of GLIA

To: scaram(o)uche who wrote (554)	2/13/1999 3:37:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

I just got a strange private message here at SI. As most here know, I prefer to keep my communications public, out in the threads, or to not have them at all. I have no interest in VRGN. I posted, ages ago, to the VRGN thread. I did such because there was a person in the thread posturing as one who could give professional investment advice, and she was giving absurd advice with respect to the company.

To: scaram(o)uche who wrote (554)	2/14/1999 12:09:00 AM
From: 5,17,37,5,101,...	Read Replies (1) \| Respond to of 1073

Richard, Must be our error. Reacap shows CP-358,774 in PI only and Yahoo news shows OSIP with no PII news. If you could help and point to PII news I'd be grateful. Small molecule drugs obviously better, except IMCL apparently way ahead in PIII. Have already lightened up on IMCL due to smell rat and looking to invest (maybe in OSIP?) another company with promising drug. Problem: OSIP returns even lower than IMCL => market averse. Lead me to believe that market in general not like biotechs waiting for proof positive, tired of Geron Entremed crap. Jackson